CAT and Hepatic fibrosis: Curcumin nanoparticles can improve the bioavailability and biodistribution, which significantly decreased MDA and significantly improved CAT, SOD and GSH in thioacetamide (TAA) -stimulated hepatic fibrosis in rats (Radwan et al., 2024) (Figure 4).